Is Breo Ellipta Covered by Insurance?

Breo Ellipta (fluticasone furoate/vilanterol) is a prescription medication used to treat asthma and chronic obstructive pulmonary disease (COPD). Many patients wonder whether their insurance will cover this inhaled medication, especially given its high cost without coverage.

Understanding Breo Ellipta Insurance Coverage

Most insurance plans do provide coverage for Breo Ellipta, but the extent of coverage varies significantly between plans. The medication is typically considered a preferred brand-name drug on many formularies, which means it receives better coverage than non-preferred medications.

Insurance companies classify Breo Ellipta as a maintenance medication for chronic conditions. This classification often results in coverage through prescription drug benefits, though patients may face copayments or coinsurance requirements.

Private Insurance Coverage for Breo Ellipta

Most private insurance plans cover Breo Ellipta when prescribed for approved conditions. However, coverage details depend on your specific plan’s formulary and tier structure.

Common Coverage Scenarios

Employer-sponsored health plans typically place Breo Ellipta on tier 2 or tier 3 of their formularies. Tier 2 placement usually means moderate copayments, while tier 3 results in higher out-of-pocket costs. Some plans require prior authorization before covering the medication.

Individual marketplace plans purchased through healthcare exchanges also generally cover Breo Ellipta. These plans must include prescription drug coverage as an essential health benefit, making respiratory medications like Breo Ellipta accessible to patients.

Medicare Coverage for Breo Ellipta

Medicare Part D prescription drug plans typically cover Breo Ellipta for eligible conditions. Coverage varies by plan, with most placing the medication on tier 3 or tier 4 of their formularies.

Medicare Advantage plans that include prescription drug coverage also cover Breo Ellipta. These plans may offer different cost-sharing structures compared to standalone Part D plans, potentially providing better or worse coverage depending on the specific plan design.

Medicaid Coverage Options

Medicaid programs in most states cover Breo Ellipta for eligible patients. State Medicaid formularies typically include this medication as a covered benefit, though some states may require prior authorization or step therapy protocols.

Medicaid managed care plans also generally provide coverage for Breo Ellipta. Patients enrolled in these plans should check their specific plan’s formulary to understand their coverage details and any requirements.

Prior Authorization Requirements

Many insurance plans require prior authorization for Breo Ellipta before approving coverage. This process involves your healthcare provider submitting documentation that demonstrates medical necessity for the medication.

Prior authorization typically requires evidence that you have tried and failed with less expensive alternatives, or documentation of specific medical conditions that make Breo Ellipta the most appropriate treatment choice. Your doctor’s office can handle this process, though it may take several days to receive approval.

Cost Without Insurance Coverage

Without insurance coverage, Breo Ellipta generally costs between $350 to $450 per month. This high cost makes insurance coverage or alternative cost-saving options essential for most patients.

The medication’s price reflects its status as a brand-name combination therapy. Unlike single-ingredient medications that may have generic alternatives, Breo Ellipta combines two active ingredients in a specific delivery device, contributing to its higher cost.

Patient Assistance Programs

GSK, the manufacturer of Breo Ellipta, offers patient assistance programs for eligible patients. These programs can significantly reduce or eliminate out-of-pocket costs for qualifying individuals.

Eligibility Requirements

The GSK Patient Assistance Program typically serves patients who are uninsured or underinsured and meet specific income requirements. Patients with Medicare, Medicaid, or other government insurance may have different eligibility criteria.

Applications for patient assistance require documentation of income, insurance status, and prescription information. Healthcare providers can help patients complete these applications and determine eligibility.

Alternative Cost-Saving Options

For patients facing high out-of-pocket costs, several options can help reduce expenses. Universal Drugstore offers an alternative for patients seeking affordable access to prescription medications. For Breo Ellipta, you can find substantial savings when compared to the cash price at your local pharmacy.

Manufacturer discount programs may be available for commercially insured patients who face high copayments. These programs typically provide coupons or cards that reduce monthly out-of-pocket costs to a predetermined maximum amount.

Comparing Insurance Plans

During open enrollment periods, patients who rely on Breo Ellipta should carefully compare prescription drug coverage across available plans. Understanding medication costs under different insurance options helps ensure continued access to necessary treatments.

Plan comparison should include examining formulary placement, copayment amounts, deductible requirements, and any utilization management restrictions like prior authorization or step therapy protocols.

Long-Term Coverage Considerations

Since Breo Ellipta is typically prescribed as a long-term maintenance medication, patients should consider the ongoing costs of treatment when evaluating insurance options. Annual out-of-pocket maximums and deductible structures can significantly impact total yearly medication expenses.

Patients should also be aware that insurance formularies can change annually. Medications covered in one plan year may move to different tiers or require additional approvals in subsequent years. Having alternative access options can provide security against sudden coverage changes.

Getting Help with Coverage Questions

Navigating insurance coverage for prescription medications can be complex. Patients experiencing difficulties with Breo Ellipta coverage should contact their insurance company’s member services department for specific information about their plan’s coverage.

Pharmacists can also provide valuable assistance in understanding insurance benefits and exploring cost-saving options. Many pharmacies offer insurance navigation services to help patients access needed medications affordably.

For patients seeking reliable access to Breo Ellipta regardless of insurance coverage status, professional pharmacy services like Universal Drugstore can guide safe, legal options for obtaining prescription medications at competitive prices.

References

• Patient Assistance Program. GSK For You. Accessed April 16, 2026.
• GSK Prescription Medicine Patient Assistance. GSK Patient Assistance Foundation. Accessed April 16, 2026.